| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.2 | 3e-09 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-07 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.18 | 4e-07 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.2 | 6e-07 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.17 | 8e-07 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.16 | 3e-06 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.16 | 4e-06 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.18 | 7e-06 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.18 | 8e-06 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |